주식/증권
📉 부정적
3 Reasons HAE is Risky and 1 Stock to Buy Instead
요약
Over the last six months, Haemonetics’s shares have sunk to $75.12, producing a disappointing 7.2% loss - a stark contrast to the S&P 500’s 6.1% gain. This might have investors contemplating their next move.